Literature DB >> 736027

Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease.

D B Petitti, J Wingerd, F Pellegrin, S Ramcharan.   

Abstract

Analysis of data from the Walnut Creek Contraceptive Drug Study showed a significant increase in risk of venous thromboembolic disease in the absence of surgery, trauma, malignancy, pregnancy, and the puerperium for women with a previous history of thromboembolism, hypertension, diabetes, varicose veins, gallbladder disease, and cigarette smoking. Education, marital status, parity, use of noncontraceptive estrogens, and obesity were not associated with an increase in risk of the disease. When only cases of the disease in the absence of all known predisposing causes (idiopathic cases) were analyzed, both oral contraceptive use and smoking remained as independent risk factors; there was no evidence of a positive interaction between them.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 736027     DOI: 10.1093/oxfordjournals.aje.a112646

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

Review 1.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.

Authors:  Jula K Inrig; Huiman X Barnhart; Donal Reddan; Uptal D Patel; Shelly Sapp; Robert M Califf; Ajay K Singh; Lynda A Szczech
Journal:  Am J Kidney Dis       Date:  2012-04-25       Impact factor: 8.860

Review 3.  Postmenopausal osteoporosis.

Authors:  J C Stevenson; M I Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

4.  Bilateral pulmonary emboli after bilateral mastectomy in a 15-year-old boy with hypogonadism: A case report.

Authors:  J R Piggott; Arjang Yazdani
Journal:  Can J Plast Surg       Date:  2010

Review 5.  The adverse effects of hormone replacement therapy.

Authors:  A Tavani; C La Vecchia
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

6.  A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; J C Todd; T J Williams; K D MacRae; F Tyrer; G M Leydon
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

Review 7.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

8.  Four decades of research on hormonal contraception.

Authors:  Diana B Petitti; Stephen Sidney
Journal:  Perm J       Date:  2005

Review 9.  Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.

Authors:  Elizabeth J Bell; Aaron R Folsom; Pamela L Lutsey; Elizabeth Selvin; Neil A Zakai; Mary Cushman; Alvaro Alonso
Journal:  Diabetes Res Clin Pract       Date:  2015-11-10       Impact factor: 5.602

10.  Does cigarette smoking alter platelet aggregation in women receiving the contraceptive pill?

Authors:  G Crooks; S Copeland; G D Johnston
Journal:  Ulster Med J       Date:  1988-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.